XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699,601 | -9.5% | 20,480 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $773,156 | +109.7% | 20,081 | +94.9% | 0.00% | 0.0% |
| Q1 2023 | $368,780 | -5.9% | 10,304 | +3.6% | 0.00% | 0.0% |
| Q4 2022 | $392,092 | +8.0% | 9,944 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $363,000 | +18.6% | 10,044 | 0.0% | 0.00% | – |
| Q2 2022 | $306,000 | -7.8% | 10,044 | -7.6% | 0.00% | – |
| Q1 2022 | $332,000 | -7.3% | 10,867 | -5.4% | 0.00% | – |
| Q4 2021 | $358,000 | +114.4% | 11,484 | +5.1% | 0.00% | – |
| Q3 2021 | $167,000 | +57.5% | 10,928 | -5.0% | 0.00% | – |
| Q2 2018 | $106,000 | +82.8% | 11,500 | -3.2% | 0.00% | – |
| Q1 2018 | $58,000 | -7.9% | 11,875 | -46.5% | 0.00% | – |
| Q4 2017 | $63,000 | -3.1% | 22,200 | +2.3% | 0.00% | – |
| Q3 2017 | $65,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |